HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that members of the management team will participate in the H.C. Wainwright 26^th Annual Global Investment Conference, taking place from September 9th-11th, 2024 in New York.

Read more at globenewswire.com